+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

  • Report
  • November 2025
  • 400 Pages
  • Global
From
From
Janus Kinase (JAK) Inhibitors Market 2026-2030 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2026-2030

  • Report
  • January 2026
  • 280 Pages
  • Global
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
Monoclonal Antibodies (MAs) Market Report 2026 - Product Thumbnail Image

Monoclonal Antibodies (MAs) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Arthritis Monoclonal Antibodies Market Report 2026 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market Report 2026 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Bispecific Antibodies - Global Strategic Business Report - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report

  • Report
  • March 2026
  • 104 Pages
  • Global
From
Loading Indicator